img

Intravenous Membrane Oxygenator Market Status and Trend Analysis 2017-2034 (COVID-19 Version)


Published on: 2024-01-04 | No of Pages : 95 | Industry : Life & Medical

Publisher : 9 | Format : PDF

Intravenous Membrane Oxygenator Market Status and Trend Analysis 2017-2034 (COVID-19 Version)

Summary

Further key aspects of the report indicate that
Chapter 1Research ScopeProduct Definition, Type, End-Use & Methodology
Chapter 2Global Industry Summary
Chapter 3Market Dynamics
Chapter 4Global Market Segmentation by region, type and End-Use
Chapter 5North America Market Segmentation by region, type and End-Use
Chapter 6Europe Market Segmentation by region, type and End-Use
Chapter 7Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8South America Market Segmentation by region, type and End-Use
Chapter 9Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10Market Competition by Companies
Chapter 11Market forecast and environment forecast.
Chapter 12Industry Summary.

The global Intravenous Membrane Oxygenator market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.


Based on the type of product

the global Intravenous Membrane Oxygenator market segmented into
Silicon Membrane Oxygenator
Hole Polypropylene Membrane Oxygenator

Based on the end-use

the global Intravenous Membrane Oxygenator market classified into
Neonatal Cardiovascular Surgery
Adult Cardiovascular Surgery

Based on geography

the global Intravenous Membrane Oxygenator market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]

And the major players included in the report are


Xenios AG (Germany)
Abbott Diabetes Care, Inc. (USA)
Vital Therapies, Inc. (USA)
Baxter International, Inc. (USA)
Asahi Kasei Medical Co., Ltd. (Japan)
Medtronic, Inc. (USA)
HeartWare International, Inc. (USA)
Fresenius Medical Care AG & Co. KGaA (Germany)
Thoratec Corp. (USA)
Toray Medical Co., Ltd. (Japan)
Nikkiso Co., Ltd. (Japan)
Nipro Corporation (Japan)
SynCardia Systems, Inc. (USA)
Terumo Heart, Inc. (USA)

Table of Content

Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL INTRAVENOUS MEMBRANE OXYGENATOR INDUSTRY
2.1 Summary about Intravenous Membrane Oxygenator Industry
2.2 Intravenous Membrane Oxygenator Market Trends
2.2.1 Intravenous Membrane Oxygenator Production & Consumption Trends
2.2.2 Intravenous Membrane Oxygenator Demand Structure Trends
2.3 Intravenous Membrane Oxygenator Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Silicon Membrane Oxygenator
4.2.2 Hole Polypropylene Membrane Oxygenator
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Neonatal Cardiovascular Surgery
4.3.2 Adult Cardiovascular Surgery
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Silicon Membrane Oxygenator
5.2.2 Hole Polypropylene Membrane Oxygenator
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Neonatal Cardiovascular Surgery
5.3.2 Adult Cardiovascular Surgery
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Silicon Membrane Oxygenator
6.2.2 Hole Polypropylene Membrane Oxygenator
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Neonatal Cardiovascular Surgery
6.3.2 Adult Cardiovascular Surgery
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Silicon Membrane Oxygenator
7.2.2 Hole Polypropylene Membrane Oxygenator
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Neonatal Cardiovascular Surgery
7.3.2 Adult Cardiovascular Surgery
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Silicon Membrane Oxygenator
8.2.2 Hole Polypropylene Membrane Oxygenator
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Neonatal Cardiovascular Surgery
8.3.2 Adult Cardiovascular Surgery
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Silicon Membrane Oxygenator
9.2.2 Hole Polypropylene Membrane Oxygenator
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Neonatal Cardiovascular Surgery
9.3.2 Adult Cardiovascular Surgery
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Xenios AG (Germany)
10.1.2 Abbott Diabetes Care, Inc. (USA)
10.1.3 Vital Therapies, Inc. (USA)
10.1.4 Baxter International, Inc. (USA)
10.1.5 Asahi Kasei Medical Co., Ltd. (Japan)
10.1.6 Medtronic, Inc. (USA)
10.1.7 HeartWare International, Inc. (USA)
10.1.8 Fresenius Medical Care AG & Co. KGaA (Germany)
10.1.9 Thoratec Corp. (USA)
10.1.10 Toray Medical Co., Ltd. (Japan)
10.1.11 Nikkiso Co., Ltd. (Japan)
10.1.12 Nipro Corporation (Japan)
10.1.13 SynCardia Systems, Inc. (USA)
10.1.14 Terumo Heart, Inc. (USA)
10.2 Intravenous Membrane Oxygenator Sales Date of Major Players (2017-2020e)
10.2.1 Xenios AG (Germany)
10.2.2 Abbott Diabetes Care, Inc. (USA)
10.2.3 Vital Therapies, Inc. (USA)
10.2.4 Baxter International, Inc. (USA)
10.2.5 Asahi Kasei Medical Co., Ltd. (Japan)
10.2.6 Medtronic, Inc. (USA)
10.2.7 HeartWare International, Inc. (USA)
10.2.8 Fresenius Medical Care AG & Co. KGaA (Germany)
10.2.9 Thoratec Corp. (USA)
10.2.10 Toray Medical Co., Ltd. (Japan)
10.2.11 Nikkiso Co., Ltd. (Japan)
10.2.12 Nipro Corporation (Japan)
10.2.13 SynCardia Systems, Inc. (USA)
10.2.14 Terumo Heart, Inc. (USA)
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT

List of Figure

List of Table
Table Intravenous Membrane Oxygenator Product Type Overview
Table Intravenous Membrane Oxygenator Product Type Market Share List
Table Intravenous Membrane Oxygenator Product Type of Major Players
Table Brief Introduction of Xenios AG (Germany)
Table Brief Introduction of Abbott Diabetes Care, Inc. (USA)
Table Brief Introduction of Vital Therapies, Inc. (USA)
Table Brief Introduction of Baxter International, Inc. (USA)
Table Brief Introduction of Asahi Kasei Medical Co., Ltd. (Japan)
Table Brief Introduction of Medtronic, Inc. (USA)
Table Brief Introduction of HeartWare International, Inc. (USA)
Table Brief Introduction of Fresenius Medical Care AG & Co. KGaA (Germany)
Table Brief Introduction of Thoratec Corp. (USA)
Table Brief Introduction of Toray Medical Co., Ltd. (Japan)
Table Brief Introduction of Nikkiso Co., Ltd. (Japan)
Table Brief Introduction of Nipro Corporation (Japan)
Table Brief Introduction of SynCardia Systems, Inc. (USA)
Table Brief Introduction of Terumo Heart, Inc. (USA)
Table Products & Services of Xenios AG (Germany)
Table Products & Services of Abbott Diabetes Care, Inc. (USA)
Table Products & Services of Vital Therapies, Inc. (USA)
Table Products & Services of Baxter International, Inc. (USA)
Table Products & Services of Asahi Kasei Medical Co., Ltd. (Japan)
Table Products & Services of Medtronic, Inc. (USA)
Table Products & Services of HeartWare International, Inc. (USA)
Table Products & Services of Fresenius Medical Care AG & Co. KGaA (Germany)
Table Products & Services of Thoratec Corp. (USA)
Table Products & Services of Toray Medical Co., Ltd. (Japan)
Table Products & Services of Nikkiso Co., Ltd. (Japan)
Table Products & Services of Nipro Corporation (Japan)
Table Products & Services of SynCardia Systems, Inc. (USA)
Table Products & Services of Terumo Heart, Inc. (USA)
Table Market Distribution of Major Players
Table Global Major Players Sales Revenue (Million USD) 2017-2020e
Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
Table Global Intravenous Membrane Oxygenator Market Forecast (Million USD) by Region 2021f-2026f
Table Global Intravenous Membrane Oxygenator Market Forecast (Million USD) Share by Region 2021f-2026f
Table Global Intravenous Membrane Oxygenator Market Forecast (Million USD) by Demand 2021f-2026f
Table Global Intravenous Membrane Oxygenator Market Forecast (Million USD) Share by Demand 2021f-2026f